Applied Psychedelic-Assisted Therapy: Cases, Conditions, and Context

$1,250 CAD + tax

Facilitated by Deanna Rogers H BA, MA C (in progress), Dr. Joe Flanders PhD, Dr. Patricia Rockman MD, CCFP, Dr. Devon Christie MD, CCFP, IFMCP, RTC, Dr. Paul Thielking MD, and Cody Callon MSW

Prerequisites required:

  1. Fundamentals of Psychedelic-Assisted Therapy
  2. Experience with motivational interviewing

If you do not have this, please reach out to training@numinus.com for recommendations to support you.

March 28 to May 2, 2023 Online every Tuesday from 9am - 12pm PT / 12pm - 3pm ET

This highly experiential, interactive, and case-based approach will guide participants to apply current psychedelic-assisted therapy approaches to mood and anxiety disorders, post-traumatic stress, addictions, and distress associated with end-of-life care. We will explore current psychotherapeutic practices and psychedelic medicines and their relevance to specific conditions and/or symptoms. We will also address such issues as medical error in diagnosis, contraindications, and potential challenges and risks when delivering psychedelic-assisted therapy.

This course has been accredited through the Canadian Psychological Association (CPA), the l'Ordre des psychologues du Québec (OPQ), and the Canadian Counselling and Psychotherapy Association (CCPA).

Learn how to apply psychedelic-assisted therapy into your practice

Through this 6-week program, you will learn how to approach problems using relevant readings and research, and how to apply this knowledge to psychedelic-assisted therapy using case-based learning. The cases will explore decision making regarding what medicine and psychotherapeutic approaches may be most appropriate in specific contexts. We will focus on four key indications: Mood and anxiety disorders, post-traumatic stress, addictive disorders, chronic and serious illnesses.

After this course, you'll be able to:

  • Determine the symptoms and appropriate treatments for the conditions presented

  • Integrate different perspectives regarding assessment and treatment approaches applied to psychedelic-assisted therapy

  • Discuss key psychedelic-assisted therapy research and proposed therapeutic mechanisms

  • Apply best practices for preparation, medicine, and integration sessions

  • Assess client's suitability for treatment according to relative and absolute contraindications

  • Identify potential challenges and risks associated with these disorders and limitations of psychedelic-assisted therapy as a brief intervention

PHRI

Meet your facilitators:

Deanna Rogers H BA, MA C (in progress)

Course Facilitator

Deanna has been working with plant medicines for over the last decade for personal healing and discovery. She has worked with the Temple of the Way of Light, The Integration Circle, and has run her own private practice for the last five years. She has also collaborated with psychedelic leaders such as Double-Blind Magazine and Psychedelics Today. She has worked in this field for the last ten years and has supported hundreds of people with many aspects of plant medicine and psychedelic experiences including applicant assessment, program design, preparation, retreat facilitation, group processing, and integration support, and has run several psychedelic harm reduction focused consultation groups for healthcare professionals. Her goal is to empower people to cultivate a deep connection to self, to help integrate trauma and align to their path going forward. She has trained with and is inspired by Indigenous Healers, Dr. Gabor Maté, Compassionate Inquiry, Somatic Experiencing, and is currently doing her master's in counseling psychology. Curiosity and compassion are two of the main tools that she brings to this work.

Deanna Rogers

Dr. Joe Flanders PhD

Topic: Mood and anxiety disorders

Dr. Flanders is a psychologist and the Founder and Regional Director of Mindspace. He obtained his PhD in Clinical Psychology from McGill University and completed a postdoctoral fellowship at the University of Wisconsin-Madison. He is also an Assistant Professor (Professional) in the McGill University Psychology Department and the Vice President of Practitioner Training at Numinus Wellness. He is licensed with the Québec Order of Psychologists. In his active psychotherapy practice, he supports the healing of anxiety, depression, post-traumatic stress, work stress, relationship problems, and personal and spiritual growth. Joe has been trained to deliver psychedelic-assisted therapy through Numinus and the Multidisciplinary Association of Psychedelic Studies (MAPS). He also has extensive training in Internal Family Systems therapy (IFS), Cognitive Behaviour Therapy (CBT), Acceptance and Commitment Therapy (ACT), and mindfulness-based psychotherapy. He holds the Advanced Mindfulness-Based Cognitive Therapy (MBCT) Facilitation Certification from the Centre for Mindfulness Studies (CMS) and the Factor-Inwentash Faculty of Social Work at the University of Toronto (FIFSW) as well as the Advanced Mindfulness-Based Stress Reduction (MBSR) Facilitation Certification from the CMS. He is an approved MBSR mentor with CMS.

Joe Flanders

Dr. Patricia Rockman MD, CCFP

Topic: Mood and anxiety disorders

Dr. Rockman is a physician with a focused practice in mental health. She is the co-founder of and a curriculum developer at the Centre for Mindfulness Studies in Toronto, a consultant to Numinus Wellness, and an Associate Professor at the University of Toronto, Department of Family and Community Medicine, cross-appointed to Psychiatry. She was the Chair of the Ontario College of Family Physicians Collaborative Mental Health Care Network for 10 years. She has written extensively on mindfulness and mental health care and is the co-author of five books. She has extensive experience in curriculum development, program design, and teaching healthcare providers in the area of continuing professional development.

Patricia Rockman

Dr. Devon Christie MD, CCFP, IFMCP, RTC

Topic: Post-traumatic stress

Dr. Christie is a clinical instructor with the UBC Department of Medicine and has a focused practice in chronic pain management. She is also a Registered Counsellor emphasizing Relational Somatic Therapy for trauma resolution, and a certified Mindfulness Based Stress Reduction teacher (UCSD). She is trained to deliver both MDMA-assisted psychotherapy for PTSD (MAPS USA) and KAT. She teaches for the California Institute of Integral Studies Certificate Program in Psychedelic Therapy and Research, the Integrative Psychiatry Institute Certificate Program in Psychedelic Assisted Therapy, and the ONCA Foundation Psychedelic Therapy program. She is a Principal Investigator and study therapist for a current Canadian MAPS PBC-sponsored 20-participant open-label clinical trial investigating MDMA-assisted psychotherapy for PTSD. Devon is the Medical and Therapeutic Services Director with Numinus Wellness Inc. and is a recognized speaker and expert on the potential for incorporating psychedelic assisted therapies in an improved health care model for the future.

Devon Christie

Dr. Paul Thielking MD

Topic: The mental health impact of living with a chronic or serious medical illness

Dr. Paul Thielking is board certified in psychiatry, hospice & palliative medicine, and integrative medicine. Dr. Thielking is the principal investigator for a psilocybin enhanced group psychotherapy intervention for cancer patients with depression and a co-investigator on a study for KAT for opioid use disorder. He has extensive experience with creating innovative group therapy interventions for patients with serious illness and has successfully integrated KAT services within an academic outpatient oncology clinic for cancer patients with depression. Dr. Thielking was director of psycho-oncology at the University of Utah Huntsman Cancer Institute for five years and was previously an associate professor in the department of psychiatry at the university of Utah. He was also the medical director of the tobacco treatment program at the Huntsman Cancer Institute. He has extensive experience with medical students, residents and fellows. Dr. Thielking is a graduate of the California Institute of Integrative Studies' Certification of Psychedelic Therapy and Research program.

Paul Thielking

Cody Callon MSW

Topic: Addictive disorders

Cody has over 15 years' experience as a social worker and researcher in the field of addictions and mental health. He addresses issues such as addiction, trauma, depression, anxiety, relationships, grief and loss, and personal growth. Cody has a Bachelor of Arts degree in Psychology and a Master of Social Work degree from University of British Columbia.

Cody is also a graduate of the California Institute of Integral Studies Psychedelic-assisted Psychotherapy and Research certificate program and has additional training in MDMA-AT and KAT.

Cody is the Lead of Psychedelic Programs and Numinus where he provides KAT and is contributing to the development of a variety of clinical and research programs. He has also served as a therapist on a study using MDMA-assisted psychotherapy to treat post-traumatic stress disorder.

Cody's therapeutic orientations include relational somatic therapy, compassionate inquiry, mindfulness based counseling, and motivational interviewing. Cody is passionate about providing preparation and integration support for people working with plant medicines and psychedelics. Cody draws from his academic training, professional experiences, psychedelic research, and his own medicine work and contemplation practices to inform his work.

Cody Callon

FAQs

  • Are there prerequisites for this course?
    • Yes, you will need to complete the following before registering:
      • Fundamentals of Psychedelic-Assisted Therapy (8-weeks)
      • Familiarity and experience with motivational interviewing. If you do not have this, please reach out to training@numinus.com for recommendations to support you.
  • Will a certificate of completion be offered to participants?
    • Yes - for 24 hours.
  • If I'm unable to join a session, will a recording be provided to me?
    • You will need to be able to commit to all the live sessions in order to receive a proof of completion certificate. Please email training@numinus.com if you have any special circumstances.
  • Can I join even if I live outside of Canada?
    • Yes, just be mindful of the time zones!
  • Still have questions?

Refund Policy

If you are unable to attend the course, please send an e-mail confirming your cancellation to training@numinus.com. A 10% administration fee will be charged for any cancellations, based on the total cost of the course, plus tax. If you have any questions, please reach out to our team and we would be happy to support you.

Disclaimer

The continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes only. Please be aware that certain psychedelic substances still remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice and are not a substitute for professional medical advice and treatment.